A study to compare the relative potency of salbutamol administered via metered dose inhalers containing propellants HFA-152a to HFA-134a in mild asthmatics aged 18 to 65 inclusive.

2024-511220-14-00 Protocol 219729 Human pharmacology (Phase I) - Other Authorised, recruitment pending

Status Authorised, recruitment pending · 4 EU/EEA countries · 7 sites · Protocol 219729

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Authorised, recruitment pending
Participants planned 150
Countries 4
Sites 7

Mild Asthma

Key facts

Sponsor
Glaxosmithkline Research & Development Limited
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Respiratory Tract Diseases [C08]
Decision date (initial)
2024-09-27
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Mild Asthma

VersionLevelCodeTermSystem organ class
20.0 LLT 10036654 Prevention 10042613

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Glaxosmithkline Research & Development Limited

Sponsor organisation
Glaxosmithkline Research & Development Limited
Address
G S K House, 980 Great West Road 980 Great West Road
City
Brentford
Postcode
TW8 9GS
Country
United Kingdom

Scientific contact point

Organisation
Glaxosmithkline Research & Development Limited
Contact name
EU GSK Clinical Trials Call Center

Public contact point

Organisation
Glaxosmithkline Research & Development Limited
Contact name
EU GSK Clinical Trials Call Center

Locations

4 EU/EEA countries · 7 investigational sites

By country

CountryMS statusPlanned subjectsSites
Bulgaria Authorised, recruitment pending 26 3
Germany Authorised, recruitment pending 20 1
Poland Authorised, recruitment pending 10 1
Romania Ended 10 2
Rest of world
United Kingdom
84

Investigational sites

Bulgaria

3 sites · Authorised, recruitment pending
Medical Center Comac Medical Ltd.
Not Applicable, Ulitsa Sveti Georgi Sofiyski 3, 1606, Sofia
Medical Center Comac Medical Ltd.
Not Applicable, Ulitsa Urvich 13, Krasno Selo District, Sofia
Multispecialty hospital for active treatment Sveta Sofia EOOD
Department of Internal Diseases, Bulevard Bilgariya 104, 1404, Sofiya

Germany

1 site · Authorised, recruitment pending
The Fraunhofer Institute For Toxicology And Experimental Medicine ITEM
Clinical Airway Research, Nikolai-Fuchs-Strasse 1, Gross Buchholz, Hanover

Poland

1 site · Authorised, recruitment pending
Biokinetica S.A.
ND, Ul. Nadwislanska 37, 05-410, Jozefow

Romania

2 sites · Ended
Centrul Medical Monza S.R.L.
Wards 1, 2, 3, 4, 5, 6,7, Intrarea Tudor Stefan 38-40, 011658, Bucharest
Spitalul Clinic Judetean De Urgenta Cluj
Ophtalmology building, Wards 33, 34, 35, Strada Clinicilor 3-5, 400006, Cluj-Napoca

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-06-07 Germany Acceptable
2024-09-16
2024-09-18
2 SUBSTANTIAL MODIFICATION SM-1 2024-10-23 Germany Acceptable 2024-11-22
3 SUBSTANTIAL MODIFICATION SM-3 2025-04-02 Germany Acceptable
2025-05-14
2025-05-16